EUVIMEDEUVIMED entdecken
Crossref

PKA-dependent phosphorylation of PSMG1 reduces bortezomib sensitivity in hepatocellular carcinoma

Wei-Jing Liu, Shi-Jie Zeng, Song-Wang Cai, You-Qing Zhu, Yi-Ping Huang, Wan-Yin Niu, Xiao-Peng Song, Ze-Hui Lan, Meng-Jie Wang, Hong-Sheng Bao, Zhi Shi

Drug Resistance Updates · 2027-01 · 90 · 101495

DOI: 10.1016/j.drup.2026.101495 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Drug Resistance Updates, 2027-01. Verfasst von Wei-Jing Liu und 10 weiteren Autor:innen. Beteiligte Einrichtung: Guangdong Provincial Key Laboratory of Pharmaceutical Preparations Research and Evaluation, Guangdong Provincial Engineering Center of Topical Precis…. Die Arbeit nennt 92 Literaturangaben. Gefördert von: Department of Science and Technology of Guangdong Province, Guangdong Pharmaceutical College, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

AIMS: This study aimed to characterize PSMG1 expression and its phosphorylation status in hepatocellular carcinoma (HCC), and dissect its functional role in regulating bortezomib (BTZ) chemosensitivity. METHODS: Western blotting, Flag co-immunoprecipitation and GST pull-down assays were applied to profile protein abundance, protein-protein binding and phosphorylation signaling cascades. Flow cytometry quantified apoptotic cell populations. Fluorogenic peptide substrates were utilized to measure cellular chymotrypsin-like proteasome activity. MTT, colony formation and Transwell migration assays were performed to evaluate proliferative and migratory phenotypes. In vivo anti-tumor efficacy of BTZ monotherapy and BTZ/H89 co-treatment was validated in subcutaneous HCC xenograft mouse models. RESULTS: PSMG1 protein was aberrantly overexpressed in HCC tissues, and high PSMG1 abundance independently predicted dismal patient survival. Genetic ablation of PSMG1 suppressed chymotrypsin-like proteasome activity and sensitized HCC cells to BTZ, without altering intrinsic cell proliferation or migratory capacity. Protein kinase A (PKA) physically bound PSMG1 and was associated with its phosphorylation at residues T18 and T54. This post-translational modification was correlated with elevated chymotrypsin-like proteasome activity and reduced sensitivity of HCC cells to BTZ. Consistently, pharmacological blockade of PKA via H89 enhanced BTZ cytotoxicity in HCC. Immunohistochemical profiling revealed elevated PKA-pT197 levels in HCC lesions, which exhibited a modest positive correlation with PSMG1-pT18 phosphorylation signals. CONCLUSIONS: PKA activity is associated with PSMG1 phosphorylation, which may contribute to reduced BTZ sensitivity in HCC. Pharmacological inhibition of PKA with H89 enhanced bortezomib cytotoxicity in preclinical HCC models, providing a preliminary rationale for combination strategies to increase proteasome inhibitor sensitivity in HCC management.

Schlagwörter

Stichwörter der Autor:innen

BortezomibHepatocellular carcinomaPKAPSMG1Protein phosphorylation

Autor:innen und Institutionen

  • Guangdong Provincial Key Laboratory of Pharmaceutical Preparations Research and Evaluation, Guangdong Provincial Engineering Center of Topical Precise Drug Delivery System, MOE Engineering Research Center of Small Molec…
  • Cancer Minimally Invasive Therapies Centre, Guangdong Second Provincial General Hospital, Department of Cell Biology & Institute of Biomedicine, Guangdong Provincial Biotechnology & Engineering Technology Research Cente…
  • Department of Surgery, the First Affiliated Hospital of Jinan University, Guangzhou, Guangdong 510632, China.

Förderung

  • Department of Science and Technology of Guangdong Province
  • Guangdong Pharmaceutical College
  • National Natural Science Foundation of China

Zitieren

APA

Liu, W. J., Zeng, S. J., Cai, S. W., Zhu, Y. Q., Huang, Y. P., Niu, W. Y., Song, X. P., Lan, Z. H., Wang, M. J., Bao, H. S., & Shi, Z. (2027). PKA-dependent phosphorylation of PSMG1 reduces bortezomib sensitivity in hepatocellular carcinoma. Drug Resistance Updates, 90, 101495. https://doi.org/10.1016/j.drup.2026.101495

Vancouver

Liu WJ, Zeng SJ, Cai SW, Zhu YQ, Huang YP, Niu WY, et al. PKA-dependent phosphorylation of PSMG1 reduces bortezomib sensitivity in hepatocellular carcinoma. Drug Resistance Updates. 2027;90:101495. doi:10.1016/j.drup.2026.101495

BibTeX
@article{Liu2027,
  author = {Liu, Wei-Jing and Zeng, Shi-Jie and Cai, Song-Wang and Zhu, You-Qing and Huang, Yi-Ping and Niu, Wan-Yin and Song, Xiao-Peng and Lan, Ze-Hui and Wang, Meng-Jie and Bao, Hong-Sheng and Shi, Zhi},
  title = {PKA-dependent phosphorylation of PSMG1 reduces bortezomib sensitivity in hepatocellular carcinoma},
  journal = {Drug Resistance Updates},
  year = {2027},
  volume = {90},
  pages = {101495},
  doi = {10.1016/j.drup.2026.101495}
}
Kostenlos starten →